Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs
- PMID: 1335332
- PMCID: PMC1907780
- DOI: 10.1111/j.1476-5381.1992.tb14502.x
Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs
Abstract
1. We examined effects of bradykinin (BK) receptor antagonists on airway hyperresponsiveness and eosinophilia in sensitized guinea-pigs that had been administered single, as well as repeated (chronic) challenges with inhaled ovalbumin. In addition, the effects of BK antagonists on antigen-induced respiratory distress during the chronic study were noted. 2. At 24 h following single antigen challenge, guinea-pigs exhibited airway hyperresponsiveness to the bronchoconstrictor effect of i.v. histamine, characterized by a left shift in the dose-response curve. In addition, responses to the maximum dose of histamine that could be used were significantly increased in hyperresponsive guinea-pigs. The percentages of bronchoalveolar fluid, eosinophil and neutrophils also increased. 3. A BK B1 receptor antagonist, desArg9-[Leu8]-BK, significantly inhibited airway hyperresponsiveness induced by single antigen challenge. A B2 receptor antagonist, D-Arg-[Hyp3, Thi5,8,D-Phe7]-BK (NPC 349) had a small, but statistically significant inhibitory effect on responsiveness to the highest histamine dose in challenged animals. DesArg9-[Leu8]-BK significantly inhibited the neutrophilia, whereas NPC 349 inhibited infiltration by both cell types. 4. Chronic antigen challenge also caused airway hyperresponsiveness to i.v. acetylcholine (ACh), distinguished by an increase in the slope of the dose-response curve. Thus, the magnitude of the bronchoconstrictor responses to the maximum dose of ACh that could be used was significantly increased. No change in sensitivity to ACh was evident. Marked eosinophilia was also noted in the trachea, bronchi and lung parenchyma. 5. Airway hyperresponsiveness and eosinophilia, induced by chronic antigen challenge, were markedly inhibited by the B2 antagonists, D-Arg-[Hyp3,D-Phe7]-BK (NPC 567) or D-Arg-[Hyp3,Thi5d-Tic7,Tic8]-BK (NPC 16731).NPC 16731 also abolished antigen-induced cyanosis, and delayed the onset of dyspnoea,doubling the time taken for animals to exhibit respiratory distress.6. The ability of BK receptor antagonists to inhibit antigen-induced airway hyperresponsiveness, in addition to eosinophilia, indicates an important role for endogenous kinins. Moreover, the abrogation of eosinophil infiltration suggests that BK has a significant function in maintaining allergic inflammation of the airways.
Similar articles
-
Inhibitory effect of NPC-17731 on BK-induced and antigen-induced airway reactions in guinea-pigs.Clin Exp Allergy. 1998 May;28(5):635-43. doi: 10.1046/j.1365-2222.1998.00264.x. Clin Exp Allergy. 1998. PMID: 9645601
-
D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors.Br J Pharmacol. 1991 Apr;102(4):785-7. doi: 10.1111/j.1476-5381.1991.tb12251.x. Br J Pharmacol. 1991. PMID: 1649657 Free PMC article.
-
Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.Eur J Pharmacol. 1992 Mar 12;225(3):235-44. doi: 10.1016/0922-4106(92)90025-q. Eur J Pharmacol. 1992. PMID: 1325366
-
The potential role of bradykinin antagonists in the treatment of asthma.Agents Actions Suppl. 1992;38 ( Pt 3):439-49. Agents Actions Suppl. 1992. PMID: 1462878 Review.
-
Bradykinin receptors and their antagonists.Eur J Pharmacol. 1998 May 1;348(1):1-10. doi: 10.1016/s0014-2999(98)00165-4. Eur J Pharmacol. 1998. PMID: 9650825 Review.
Cited by
-
Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines.Am J Pathol. 1998 Dec;153(6):1885-93. doi: 10.1016/S0002-9440(10)65702-1. Am J Pathol. 1998. PMID: 9846978 Free PMC article.
-
Modelling the electrophysiological endothelial cell response to bradykinin.Eur Biophys J. 2003 Jul;32(4):370-80. doi: 10.1007/s00249-003-0279-x. Epub 2003 Feb 20. Eur Biophys J. 2003. PMID: 12851795
-
An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction.Infect Disord Drug Targets. 2022;22(7):81-91. doi: 10.2174/1871526522666220321153712. Infect Disord Drug Targets. 2022. PMID: 35319400
-
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications.FASEB J. 2020 Jun;34(6):7265-7269. doi: 10.1096/fj.202000967. Epub 2020 May 2. FASEB J. 2020. PMID: 32359101 Free PMC article.
-
Bradykinin stimulates MMP-2 production in guinea pig tracheal smooth muscle cells.Inflammation. 2003 Oct;27(5):307-15. doi: 10.1023/a:1026080527573. Inflammation. 2003. PMID: 14635788
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources